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Identity 
Other names: AD3L, AD4, PS2, STM2 




Twelve exons, spans approximately 26.7 kb of genomic 
DNA in the centromere to telomere orientation, the 
translation initation codon is in exon 4 and the stop 
codon in exon 12. 
Transcription 
mRNA of approximately 2.3 kb. Two alternatively 
spliced transcript variants encoding different isoforms 





The open reading frame encodes a 448 amino acid 
protein, with an estimated molecular weight of 50 kDa.  
It is a multi-spanning transmembrane protein with a 
predicted 9 transmembrane domains. Heterogeneous 
proteolytic processing generates N-terminal and C-
terminal fragments. 
Expression 
Neuronal (higher levels in hippocampus and 
cerebellum). Isoform 1 is seen in the placenta, skeletal 
muscle and heart while isoform 2 is seen in the heart, 
brain, placenta, liver, skeletal muscle and kidney. (In 
isoform 2 amino-acids 263-296 are missing). 
Localisation 
Endoplasmic reticulum, plasma membrane, golgi 
apparatus. 
Function 
Catalytic core of the gamma-secretase complex. This 
complex catalyses the intramembrane cleavage of 
single-pass membrane proteins such as Notch and the 
Amyloid Precursor Protein (APP) to give intracellular 
signaling. The released intracellular domains of Notch 
or APP form complexes with other proteins to regulate 
gene transcription. 
Homology 
The PSEN2 gene is conserved in chimpanzee, dog, 
cow, mouse, rat, chicken, and zebrafish. 
 
 
Presenilin 2 transcript, lines indicate introns and boxes exons. Untranslated regions are represented as yellow boxes and coding regions 
as red boxes. 
 
Presenilin 2 protein domains, bright blue boxes are transmembrane domains (TM). 
 















Cruts et al., 1998; Guerreiro et al., 
2008 
Arg71Trp  AD Guerreiro et al., 2008 
Thr122Pro AD Finckh et al., 2000; 2005 
Ser130Leu AD 
Sorbi et al., 2002; Tedde et al., 
2003; Tomaino et al., 2007 
Val139Met AD Bernardi et al., 2008 
Asn141Ile AD 
Levy-Lahad et al., 1995; Rogaev et 
al., 1995 
Met174Val  AD Guerreiro et al., 2008 
Ser175Cys AD Piscopo et al., 2008 
Gln228Leu  AD Zekanowski et al., 2003 
Met239Ile  AD Finckh et al., 2000 
Met239Val AD 
Rogaev et al., 1995; Marcon et al., 
2004 
Val393Met  AD Lindquist et al., 2008; 2009 
Thr430Met AD 
Lleo et al., 2002; Ezquerra et al., 
2003 








To et al., 2006 
Tyr231Cys  FTD Marcon et al., 2008; 2009 




Binetti et al., 2003 
Table. Mutations identified through genetic screening. AD: 
Alzheimer's Disease, FTD: Frontotemporal Dementia, LBD: 




Breast cancer is the most common form of cancer for 
women. The cancer originates from the breast tissue 
where it can be a ductal carcinoma or lobular 




Mutations (see above). 
Alzheimer's disease 
Note 
Mutations (see above) taken from the Alzheimer's 
Disease and Frontotemporal Dementia Mutation 
Database. Only pathogenic mutations are included. 
Disease 
Alzheimer's disease is the most prevalent form of 
dementia. In affected individuals the disease causes a 
progressive and permanent decline in memory and 
cognitive abilities. Neuropathogenesis is proposed to be 
a result of the accumulation of amyloid-beta peptides in 
the brain together with increased oxidative stress and 
neuroinflammation. The presenilin proteins are central 
to the gamma-secretase cleavage of the amyloid 
precursor protein (APP), releasing the amyloid-beta 
peptide. Point mutations in the presenilin genes lead to 
cases of familial Alzheimer's disease (and some 
sporadic cases) by altering APP cleavage resulting in 
excess amyloid-beta formation. 
Frontotemporal Dementia (FTD) 
Note 
Mutation (see above). 
Disease 
Frontotemporal dementia is a group of related 
conditions resulting from the progressive degeneration 
of the temporal and frontal lobes of the brain 
(frontotemporal lobar degeneration, FTLD), usually 
with the presence of abnormal intracellular protein 
accumulations. These areas of the brain play a 
significant role in decision-making, behavioral control, 
emotion and language. The disorder is often sporadic, 
familial FTD has been linked to mutations in several 
genes, including those encoding the microtubule-
associated protein tau (MAPT), progranulin (GRN), 
valosin-containing protein (VCP) and charged 
multivescicular body protein 2B (CHMP2B). 
Lewy body Dementia (DLB) 
Note 
Mutation (see above). 
Disease 
Dementia with Lewy bodies is a neurodegenerative 
disorder associated with abnormal structures (Lewy 
bodies) which are clumps of alpha-synuclein and 
ubiquitin protein in neurons found in certain areas of 
the brain. In addition to dementia, patients with 
dementia with Lewy bodies experience hallucinations, 
motor impairment, and fluctuating alertness. 
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Diagram taken from http://www.molgen.ua.ac.be/ADMutations. Coloured circles indicate mutation sites. Red: pathogenic, orange: 
pathogenic nature unclear, green: not pathogenic. 
 
To be noted 
Note 
Truncated variant PSEN2 protein (PS2V). Variant 
transcript lacks exon 5 due to alternative splicing. 
Encodes the first 119 codons of PSEN2 plus a newly 
generated five amino acids SSMAG. PS2V is detected 
in sporadic Alzheimer's disease, bi-polar and 
schizophrenia cases (Sato et al., 1999; Smith et al., 
2004). Cell-culture experiments indicate that this 
variant is upregulated under hypoxic conditions (Sato 
et al., 1999). 
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